通过逆转多巴胺运输的登德罗登德里特抑制
B H Falkenburger1, K L Barstow, I M Mintz
1Department of Pharmacology and Experimental Therapeutics, Boston University Medical Center, Boston, MA 02118, USA.
概括
研究人员发现了大脑中一种新型的自我抑制形式. 多巴胺载体阻塞阻止了多巴胺的释放,这表明这种神经元通信的载体介导释放,而不是外细胞形成.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
背景情况:
- 传统上,中枢神经系统突触涉及突触前外细胞和突触后结构.
- 树突相互作用的 dendrodendritic 通信,关于其释放机制的理解较少.
研究的目的:
- 调查黑色物质中树突干抑制的机制.
- 要确定在这种情况下的多巴胺释放是否通过常规的细胞外转移或另一种途径发生.
主要方法:
- 在老鼠大脑切片中利用了电压计和补丁记录.
- 研究了多巴胺载体阻塞对树突性多巴胺释放和神经元抑制的影响.
主要成果:
- 多巴胺载体的阻塞消除了树突性多巴胺的释放和随后的自我抑制.
- 证明,树突 dendrodendritic 自抑制依赖于载体介导的多巴胺释放,与外细胞形成不同.
结论:
- 黑色物质中的登德罗登德里特自身抑制是由载体驱动的多巴胺释放介导的,而不是外细胞分裂.
- 这一发现表明,在早期帕金森病中,多巴胺载体抑制剂 (如某些抗抑郁药) 有潜在的治疗应用.
相关概念视频
GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...


